A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART ...

When it comes to medically assisted weight loss, there’s two main schools of thought: either weight loss drugs, like the ...

1. Glucagon-like Peptide Receptor Agonists (GLP1-RA) are weight loss medications. They actually treat and reverse the metabolic reason for weight gain mainly in the brain. 2. Anyone taking a GLP1 ...

SAN FRANCISCO, CA / ACCESS Newswire / January 21, 2025 / Gala introduces a groundbreaking digital health platform that ...

Commonly used diabetes drugs could lower the risk of cardiometabolic conditions but heighten the risk of gastrointestinal and ...

SPRINGFIELD, Mo. (KY3)—When it comes to medically assisted weight loss, there are two primary schools of thought: weight loss drugs, such as the popular GLP1s Ozempic and Mounjaro, or bariatric ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

“GLP1s represent a new landscape ... dementia-protecting benefit when they found participants taking GLP-1 drugs had a decreased risk of neurocognitive conditions such as dementia and Alzheimer ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...